RSA welcomes new finance director

pharmafield logo - pharma news

Global life sciences executive search and interim management specialist RSA has appointed chartered accountant and financial strategy expert Matt Ryans as the company’s new finance director.

Working across RSA’s global network, Matt comes to the role with over a decade of experience in the financial services sector.

Matt has served as RSA’s financial controller for over a year. His previous experience included managing the finances for a small biotech firm undertaking stage II clinical trials of a new cancer therapy while working full-time as finance director for The Great Pie Shop.

Nick Stephens, CEO of RSA, said: “We believe Matt is well positioned to succeed in this new role given his broad financial knowledge and experience in the life sciences sector. He is already a well-respected member of the RSA team and we therefore feel very lucky that Matt is taking up this new position.”

In his new role, Matt will be responsible for long-term financial planning and will report directly to the CEO and management board. He will oversee RSA’s global budgeting process and manage the company’s financial risk.

Matt said: “Having worked with RSA for over a year now I have gained first-hand understanding of the quality differentiators that set the company apart from its competitors, as well as gaining insight into the company’s long-term goals. I am excited to take on this new level of responsibility and look forward to helping RSA continue to thrive as we emerge from this seemingly difficult economic period.”